Ignite Creation Date:
2025-12-24 @ 6:27 PM
Ignite Modification Date:
2025-12-30 @ 6:22 PM
Study NCT ID:
NCT06947668
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-04-27
First Post:
2025-04-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel
Sponsor:
University of Erlangen-Nürnberg Medical School
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2030-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-04-20
First Submit QC Date:
None
Study First Post Date:
2025-04-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-25
Last Update Post Date:
2025-04-27
Last Update Post Date Type:
ACTUAL